LENZ
Price
$17.14
Change
+$0.25 (+1.48%)
Updated
Dec 24 closing price
Capitalization
536.31M
Intraday BUY SELL Signals
MLTX
Price
$13.87
Change
+$0.13 (+0.95%)
Updated
Dec 24 closing price
Capitalization
982.65M
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LENZ vs MLTX

Header iconLENZ vs MLTX Comparison
Open Charts LENZ vs MLTXBanner chart's image
LENZ Therapeutics
Price$17.14
Change+$0.25 (+1.48%)
Volume$321.05K
Capitalization536.31M
MoonLake Immunotherapeutics
Price$13.87
Change+$0.13 (+0.95%)
Volume$536.46K
Capitalization982.65M
LENZ vs MLTX Comparison Chart in %
LENZ
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LENZ vs. MLTX commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LENZ is a Buy and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (LENZ: $17.14 vs. MLTX: $13.87)
Brand notoriety: LENZ and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LENZ: 25% vs. MLTX: 26%
Market capitalization -- LENZ: $536.31M vs. MLTX: $982.65M
LENZ [@Biotechnology] is valued at $536.31M. MLTX’s [@Biotechnology] market capitalization is $982.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LENZ’s FA Score shows that 1 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • LENZ’s FA Score: 1 green, 4 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, MLTX is a better buy in the long-term than LENZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LENZ’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • LENZ’s TA Score: 4 bullish, 5 bearish.
  • MLTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than LENZ.

Price Growth

LENZ (@Biotechnology) experienced а +4.70% price change this week, while MLTX (@Biotechnology) price change was -0.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

MLTX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($983M) has a higher market cap than LENZ($536M). LENZ YTD gains are higher at: -40.630 vs. MLTX (-74.386). LENZ has higher annual earnings (EBITDA): -67.7M vs. MLTX (-227.94M). MLTX has more cash in the bank: 380M vs. LENZ (202M). LENZ has less debt than MLTX: LENZ (954K) vs MLTX (75.7M). LENZ has higher revenues than MLTX: LENZ (17.5M) vs MLTX (0).
LENZMLTXLENZ / MLTX
Capitalization536M983M55%
EBITDA-67.7M-227.94M30%
Gain YTD-40.630-74.38655%
P/E Ratio48.03N/A-
Revenue17.5M0-
Total Cash202M380M53%
Total Debt954K75.7M1%
TECHNICAL ANALYSIS
Technical Analysis
LENZMLTX
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
72%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
60%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 9 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
65%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
LENZ
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIREX27.980.16
+0.58%
Principal Real Estate Securities Inst
HAIBX30.380.06
+0.20%
Hartford Balanced HLS IB
PAHSX7.250.01
+0.14%
PGIM Jennison NextGeneration Glb Opps A
LICFX17.89N/A
N/A
Lord Abbett International Equity F
GCIFX16.14-0.02
-0.12%
Green Century MSCI Intl Indx Instl

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with BHVN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then BHVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+1.48%
BHVN - LENZ
41%
Loosely correlated
+2.95%
BCYC - LENZ
40%
Loosely correlated
+0.72%
MLTX - LENZ
37%
Loosely correlated
+0.95%
CELC - LENZ
36%
Loosely correlated
+0.25%
CGON - LENZ
35%
Loosely correlated
+0.22%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.95%
KALA - MLTX
85%
Closely correlated
+12.32%
IOBT - MLTX
75%
Closely correlated
+5.50%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
-0.13%
NUVL - MLTX
48%
Loosely correlated
+0.89%
More